News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Atlantic study shows PI-sparing combos match indinavir after 48 weeks

Two more PI-sparing regimens were assessed in the international Atlantic study, which also featured amongst Monday's Late Breakers at the 39th ICAAC in San Francisco.

Published
05 March 2001
By
Anna Poppa
Adefovir rejected for US license

The US Food and Drug Administration's Anti-viral Advisory board has voted against Gilead's application for a US marketing license for adefovir. At a hearing on

Published
05 March 2001
By
Keith Alcorn
40% of French combo patients have detectable viral load

Around 40% of people taking combination therapy in France have detectable viral load, and 8% have run out of treatment options, according to a report

Published
05 March 2001
By
Keith Alcorn
Efavirenz side effects become long-term for over one in three

Central nervous system symptoms commonly seen in the weeks after starting efavirenz may persist for months or even years in a substantial proportion of patients,

Published
05 March 2001
By
Megan Nicholson
Virgin Islands conference summaries

Immediately before the holiday period, the Fifth International Conference on the Discovery and Clinical Development of Antiretroviral Therapies took place on the island of St.

Published
05 March 2001
By
Anon
UK joins new study on how to treat HIV in children: exclusive interview with Dr Gareth Tudor-Williams.

UK treatment centres are to join a major international study of HIV treatment in children which will test whether it is better to start treatment

Published
05 March 2001
By
Anna Poppa
First human study of follow-on fusion inhibitor

Delegates at the 8th Retroviruses Conference currently underway in Chicago have heard new data this morning on T-1249, a fusion inhibitor. Interest in this new

Published
05 March 2001
By
Anna Poppa
Bill Gates hints at billions of dollars for HIV vaccine

Bill Gates, the founder of Microsoft and the richest man in the world, has hinted that he will commit more money to HIV vaccine research

Published
05 March 2001
By
Anon
Gilead end development of adefovir for HIV in US; await decision in Europe

Gilead Sciences have shelved the development of their novel HIV inhibitor adefovir dipivoxil (Preveon) for the treatment of HIV disease in the US. This follows

Published
05 March 2001
By
Anna Poppa
Glaxo-Wellcome to put three anti-HIV drugs in one pill

Glaxo-Wellcome CEO Sir Richard Sykes has confirmed that the company is moving ahead swiftly with plans to combine AZT, 3TC and abacavir into one tablet.

Published
05 March 2001
By
Keith Alcorn
← Prev1...14211422142314241425...1427Next →

Filter by country